• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

    2/14/22 2:34:23 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary
    Get the next $HWKN alert in real time by email
    SC 13G/A 1 hwkn13gadec21.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13) HAWKINS INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 420261109 (CUSIP NUMBER) December 31, 2021 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 369,945 6. Shared Voting Power* 0 7. Sole Dispositive Power* 1,145,645 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,145,645 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 5.4% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: HAWKINS INC Item 1(b) Address of Issuer's Principal Executive Offices: 2381 ROSEGATE, ROSEVILLE, MINNESOTA 55113 Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. ("Price Associates") Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 420261109 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class Not Applicable Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. (2) With respect to securities owned by any one of the T. Rowe Price Funds, only the custodian for each of such Funds, has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. No other person is known to have such right, except that the shareholders of each such Fund participate proportionately in any dividends and distributions so paid. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: February 14, 2022 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President 12/31/2021
    Get the next $HWKN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $HWKN

    DatePrice TargetRatingAnalyst
    7/24/2025Mkt Perform
    Raymond James
    4/14/2025$160.00Neutral → Buy
    BWS Financial
    4/1/2025$125.00Market Outperform
    CJS Securities
    10/16/2024Buy → Neutral
    BWS Financial
    8/7/2023$62.00Neutral → Buy
    BWS Financial
    2/3/2022$44.00 → $52.00Buy
    BWS Financial
    More analyst ratings

    $HWKN
    SEC Filings

    See more
    • SEC Form DEFA14A filed by Hawkins Inc.

      DEFA14A - HAWKINS INC (0000046250) (Filer)

      6/18/25 9:01:40 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form DEFA14A filed by Hawkins Inc.

      DEFA14A - HAWKINS INC (0000046250) (Filer)

      6/18/25 8:13:57 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form DEF 14A filed by Hawkins Inc.

      DEF 14A - HAWKINS INC (0000046250) (Filer)

      6/18/25 8:13:14 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Leadership Updates

    Live Leadership Updates

    See more
    • THE TRŪ® SHRIMP COMPANIES APPOINTS HAWKINS AS EXCLUSIVE U.S. DISTRIBUTOR FOR TRŪ® CHITOSAN

      BALATON, Minn., Aug. 16, 2023 /PRNewswire/ -- The trū® Shrimp Companies, Inc. ("trū Shrimp") announced today that trū Shrimp has appointed Hawkins, Inc. ("Hawkins") (NASDAQ:HWKN) as the exclusive distributor of its trū® Chitosan products into the United States' pharmaceutical and medical device industries. trū Chitosan is derived from the exoskeletons of trū Shrimp's production of consumer shrimp. Chitosan is a molecule refined from the shell of shrimp and is used for numerous pharmaceutical and medical applications. trū Shrimp is the only United States producer of chitosan that meets the strict medical specifications of the United States Pharmacopoeia – National Formulary (USP-NF) monograph

      8/16/23 9:00:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc.  Announces Retirement of Director John McKeon

      Minneapolis, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced that John S. McKeon has notified us of his retirement from our Board of Directors and its committees effective as of December 31, 2020.  Mr. McKeon has been a member of the Board since 1984 and has served as Chair of the Board since 2005. “We will miss Jack on the Board and appreciate his many years of dedicated service to Hawkins,” said Patrick H. Hawkins, Chief Executive Officer and President. “Over the 36 years that Jack has served on the Board, we have seen Hawkins grow tremendously in both size and scope.  With his support and guidance, we have built a solid company that is poised for cont

      12/18/20 4:10:00 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • HAWKINS, INC. TO RELEASE FIRST QUARTER FISCAL 2026 FINANCIAL RESULTS ON JULY 30, 2025

      ROSEVILLE, Minn., July 16, 2025 (GLOBE NEWSWIRE) --  Hawkins, Inc. (NASDAQ:HWKN) announced today that it expects to release its financial results for its fiscal 2026 first quarter ended June 29, 2025 after the market closes on July 30, 2025 at approximately 4:10 p.m. Eastern Time.  About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities in 28 states and creates value for its customers through superb customer se

      7/16/25 8:45:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. Expands Water Treatment Footprint with Acquisition of PhillTech, LLC

      ROSEVILLE, Minn., July 01, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of PhillTech, LLC. PhillTech, located in Alabama, manufactures and distributes coagulants and corrosion control products for its water treatment customers. "As we continue to execute on our strategy to grow our water treatment business, we believe this tuck-in acquisition will help solidify and grow our production of coagulants and corrosion control products and further improve our position in this market. We have known PhillTech for many years and have built a solid working relationship with their team, having been a s

      7/1/25 9:05:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. to Participate in CJS Securities 25th Annual New Ideas Summer Conference

      ROSEVILLE, Minn, June 11, 2025 (GLOBE NEWSWIRE) -- – Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that it will participate in the CJS Securities 25th Annual New Ideas Summer Conference on July 10, 2025. The conference will be held at the Metropolis Country Club in White Plains, NY. The conference will be attended by a group of targeted institutional investors, where each company in attendance will have a presentation slot and will be available for one-on-one meetings. For more information about this conference or to schedule a meeting with Hawkins management, please contact the event coordinators or Hawkins Investor Relations

      6/11/25 9:00:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Raymond James initiated coverage on Hawkins

      Raymond James initiated coverage of Hawkins with a rating of Mkt Perform

      7/24/25 7:27:35 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins upgraded by BWS Financial with a new price target

      BWS Financial upgraded Hawkins from Neutral to Buy and set a new price target of $160.00

      4/14/25 9:28:56 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • CJS Securities initiated coverage on Hawkins with a new price target

      CJS Securities initiated coverage of Hawkins with a rating of Market Outperform and set a new price target of $125.00

      4/1/25 9:13:14 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Faulconbridge James A bought $161,899 worth of shares (1,800 units at $89.94), increasing direct ownership by 4% to 47,817 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      6/14/24 4:09:43 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Director Faulconbridge James A bought $351,036 worth of shares (4,000 units at $87.76), increasing direct ownership by 10% to 46,017 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      6/12/24 6:02:44 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Director Faulconbridge James A bought $288,907 worth of shares (3,300 units at $87.55), increasing direct ownership by 9% to 42,017 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      6/10/24 4:27:25 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP of Food and Health Sciences Jones Gregory Alan was granted 3,411 shares, increasing direct ownership by 75% to 7,980 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      5/16/25 4:30:47 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • VP-INDUSTRIAL SOLUTIONS GROUP Mangine David J. was granted 3,553 shares, increasing direct ownership by 14% to 29,104 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      5/16/25 4:30:44 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • VP - WATER TREATMENT GROUP Lange Douglas A. was granted 3,553 shares, increasing direct ownership by 14% to 28,792 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      5/16/25 4:30:37 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Financials

    Live finance-specific insights

    See more
    • HAWKINS, INC. TO RELEASE FIRST QUARTER FISCAL 2026 FINANCIAL RESULTS ON JULY 30, 2025

      ROSEVILLE, Minn., July 16, 2025 (GLOBE NEWSWIRE) --  Hawkins, Inc. (NASDAQ:HWKN) announced today that it expects to release its financial results for its fiscal 2026 first quarter ended June 29, 2025 after the market closes on July 30, 2025 at approximately 4:10 p.m. Eastern Time.  About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities in 28 states and creates value for its customers through superb customer se

      7/16/25 8:45:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. Expands Water Treatment Footprint with Acquisition of PhillTech, LLC

      ROSEVILLE, Minn., July 01, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of PhillTech, LLC. PhillTech, located in Alabama, manufactures and distributes coagulants and corrosion control products for its water treatment customers. "As we continue to execute on our strategy to grow our water treatment business, we believe this tuck-in acquisition will help solidify and grow our production of coagulants and corrosion control products and further improve our position in this market. We have known PhillTech for many years and have built a solid working relationship with their team, having been a s

      7/1/25 9:05:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results

      ROSEVILLE, Minn., May 14, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 30, 2025. Fourth Quarter Fiscal Year 2025 Highlights: Record fourth quarter sales of $245.3 million, a 10% increase over the same quarter of the prior year, led by Water Treatment segment sales growth of 21% over the same quarter in the prior year.Record fourth quarter gross profit of $52.2 million, a 15% increase over the same quarter of the prior year, contributing to record fourth quarter operating income of $24.6 million, a 22% increase over the prior year.Record fourth quarter diluted earnings per share (EPS) of $0.78, wh

      5/14/25 4:05:49 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Hawkins Inc.

      SC 13G/A - HAWKINS INC (0000046250) (Subject)

      10/31/24 11:54:59 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

      SC 13G/A - HAWKINS INC (0000046250) (Subject)

      2/13/24 5:06:13 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

      SC 13G/A - HAWKINS INC (0000046250) (Subject)

      2/9/24 9:59:13 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary